Product image of Levonorgestrel/Etinilestradiol Diario Stada Genéricos (Ethinylestradiol, Levonorgestrel) supplied by GNH India

Levonorgestrel/Etinilestradiol Diario Stada Genéricos

Active Ingredient:
Ethinylestradiol, Levonorgestrel
Origin:
EU

Levonorgestrel/Etinilestradiol Diario Stada Genéricos (Ethinylestradiol, Levonorgestrel)

Levonorgestrel/Ethinylestradiol, the active ingredient in Levonorgestrel/Ethinylestradiol Diario Stada Genericos, is a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy and helps regulate the menstrual cycle in women of reproductive age.

GNH India supplies Levonorgestrel/Ethinylestradiol Diario Stada Genericos as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Products are manufactured under EU GMP guidelines and undergo rigorous testing before release.

Manufacturer / TM Owner

Laboratorio Stada, S.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Levonorgestrel/Ethinylestradiol is a combined hormonal contraceptive used to manage reproductive health conditions.

  • Contraception: prevents pregnancy by inhibiting ovulation and altering cervical mucus.
  • Menstrual cycle regulation: reduces irregular bleeding and stabilizes cycle length.
  • Dysmenorrhea relief: lessens painful menstrual cramps through hormonal stabilization.

How It Works

  • Levonorgestrel/Ethinylestradiol combines a synthetic progestogen (levonorgestrel) with an estrogen (ethinylestradiol). The estrogen suppresses the mid‑cycle surge of luteinizing hormone (LH) and follicle‑stimulating hormone (FSH), while the progestogen reinforces this effect, preventing ovulation. Additionally, the formulation induces endometrial changes and thickens cervical mucus, creating an environment unsuitable for fertilization and implantation.

Side Effects

Oral administration of Levonorgestrel/Ethinylestradiol may be associated with a range of adverse reactions.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Headache: tension‑type or migraine‑like pain.
  • Breast tenderness: temporary swelling or discomfort.
  • Weight gain: slight increase in body weight.
  • Mood changes: irritability or emotional fluctuations.
  • Spotting: irregular light bleeding between periods.

Serious or Rare Side Effects

  • Venous thromboembolism: blood clots in deep veins.
  • Pulmonary embolism: blockage of lung arteries.
  • Stroke: cerebrovascular accident.
  • Myocardial infarction: heart attack.
  • Severe allergic reaction: rash, swelling, anaphylaxis.
  • Hepatotoxicity: liver enzyme elevation or jaundice.

Precautions & Warnings

Before prescribing Levonorgestrel/Ethinylestradiol, clinicians should consider several safety measures.

  • Contraindications: avoid in women with history of thromboembolic disorders.
  • Smoking: do not prescribe to smokers over 35 years of age.
  • Hypertension: monitor blood pressure regularly.
  • Liver disease: use with caution in hepatic impairment.
  • Pregnancy: contraindicated; ensure negative pregnancy test before initiation.
  • Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture.

Avoid Interactions

Levonorgestrel/Ethinylestradiol can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid)

  • Antiepileptics (e.g., carbamazepine, phenytoin): reduce contraceptive effectiveness.
  • Rifampin and other enzyme inducers: markedly decrease hormone levels.
  • St. John’s wort: may lead to contraceptive failure.

Moderate Interactions (Monitor Closely)

  • Antifungals (e.g., ketoconazole): increase hormone concentrations.
  • Antiretrovirals (e.g., protease inhibitors): may alter drug levels.
  • Diuretics (e.g., thiazides): may increase risk of hypertension.
  • NSAIDs (high dose): may affect bleeding patterns.

Frequently Asked Questions

Levonorgestrel/Ethinylestradiol is used as a combined oral contraceptive to prevent pregnancy and to help regulate the menstrual cycle in women of reproductive age.

The product combines an estrogen (ethinylestradiol) and a progestogen (levonorgestrel). Together they suppress the mid‑cycle LH and FSH surge, preventing ovulation, while also thickening cervical mucus and altering the endometrium to inhibit implantation.

The prescribing clinician determines the dosing regimen. Typically, one tablet is taken daily at the same time, but the exact schedule and duration are individualized based on the patient’s medical history and treatment plan.

Levonorgestrel/Ethinylestradiol is contraindicated in pregnancy (Category X) and should not be started in women who are pregnant. Use during breastfeeding is generally not recommended unless the benefits outweigh potential risks, and a healthcare professional should be consulted.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levonorgestrel/Ethinylestradiol contains a specific dose of levonorgestrel and ethinylestradiol that offers reliable ovulation suppression and cycle control. Compared with other COCs, it may have a slightly different side‑effect profile, but overall efficacy and safety are comparable when used as directed.

Store the tablets at ambient temperature, below 25 °C, in the original packaging, and protect them from moisture and direct sunlight to maintain potency throughout the shelf life.

The medication is taken orally, usually one tablet each day at the same time, without regard to meals. Consistent daily intake is essential for maintaining contraceptive effectiveness.

Serious risks include venous thromboembolism, pulmonary embolism, stroke, myocardial infarction, severe allergic reactions, and hepatotoxicity. Patients should be monitored for signs of these conditions and seek immediate medical attention if they occur.

Women with a history of thromboembolic disorders, active liver disease, known or suspected breast cancer, uncontrolled hypertension, or who are pregnant or breastfeeding should avoid this product. Smokers over 35 years of age are also advised not to use it.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ethinylestradiol, Levonorgestrel

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT